Search research articles
Contact Us
Filters
Showing results (31-40 of 68) with videos related to
Page
of 7
Sort By:
Journal of Comparative Effectiveness Research
|
February 24, 2025
Matching-adjusted indirect comparisons of efficacy outcomes between etrasimod and ozanimod for moderately to severely active ulcerative colitis
Vipul Jairath, Tim Raine, Thomas P Leahy, et al.
Journal of Comparative Effectiveness Research
|
March 17, 2025
Efficacy and safety of advanced therapies for moderately to severely active ulcerative colitis in induction and maintenance: systematic literature review and Bayesian network meta-analysis
Vipul Jairath, Tim Raine, Thomas P Leahy, et al.
Dermatology and Therapy
|
April 13, 2021
Clinical and Economic Burden of Mild-to-Moderate Atopic Dermatitis in the UK: A Propensity-Score-Matched Case-Control Study
Farah Toron, Maureen P Neary, Timothy W Smith, et al.
Arthritis Research & Therapy
|
March 25, 2026
Risk of serious infections, myocardial infarction or stroke, venous thromboembolic events, and malignancy in patients with psoriatic arthritis treated with tofacitinib compared with biologic treatments in the United States
Marina Magrey, Milena A Gianfrancesco, Lara Fallon, et al.
Rheumatology (Oxford, England)
|
March 2, 2016
Tofacitinib or adalimumab versus placebo: patient-reported outcomes from a phase 3 study of active rheumatoid arthritis
Vibeke Strand, Ronald F van Vollenhoven, Eun Bong Lee, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
May 31, 2022
Predictors of nonresponse to dupilumab in patients with atopic dermatitis: A machine learning analysis
Jashin J Wu, Chih-Ho Hong, Joseph F Merola, et al.
Rheumatology and Therapy
|
November 5, 2023
Tofacitinib Efficacy in Patients with Rheumatoid Arthritis and Probable Depression/Anxiety: Post Hoc Analysis of Phase 3 and 3b/4 Randomized Controlled Trials
Gustavo Citera, Rakesh Jain, Fedra Irazoque, et al.
ACR Open Rheumatology
|
October 30, 2025
Characterization of Second-Line Therapy After First JAK Inhibitor Use: Results From the CorEvitas Rheumatoid Arthritis Registry
Joshua F Baker, Kristi V Mizelle, Wassim Saikali, et al.
Rheumatology and Therapy
|
September 25, 2024
Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status
Alexis Ogdie, Lars E Kristensen, Enrique R Soriano, et al.
RMD Open
|
November 2, 2019
Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial
Vibeke Strand, Eduardo Mysler, Robert J Moots, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 68) with videos related to
Sort By:
Page
of 7
Journal of Comparative Effectiveness Research
|
February 24, 2025
Matching-adjusted indirect comparisons of efficacy outcomes between etrasimod and ozanimod for moderately to severely active ulcerative colitis
Vipul Jairath, Tim Raine, Thomas P Leahy, et al.
Journal of Comparative Effectiveness Research
|
March 17, 2025
Efficacy and safety of advanced therapies for moderately to severely active ulcerative colitis in induction and maintenance: systematic literature review and Bayesian network meta-analysis
Vipul Jairath, Tim Raine, Thomas P Leahy, et al.
Dermatology and Therapy
|
April 13, 2021
Clinical and Economic Burden of Mild-to-Moderate Atopic Dermatitis in the UK: A Propensity-Score-Matched Case-Control Study
Farah Toron, Maureen P Neary, Timothy W Smith, et al.
Arthritis Research & Therapy
|
March 25, 2026
Risk of serious infections, myocardial infarction or stroke, venous thromboembolic events, and malignancy in patients with psoriatic arthritis treated with tofacitinib compared with biologic treatments in the United States
Marina Magrey, Milena A Gianfrancesco, Lara Fallon, et al.
Rheumatology (Oxford, England)
|
March 2, 2016
Tofacitinib or adalimumab versus placebo: patient-reported outcomes from a phase 3 study of active rheumatoid arthritis
Vibeke Strand, Ronald F van Vollenhoven, Eun Bong Lee, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
May 31, 2022
Predictors of nonresponse to dupilumab in patients with atopic dermatitis: A machine learning analysis
Jashin J Wu, Chih-Ho Hong, Joseph F Merola, et al.
Rheumatology and Therapy
|
November 5, 2023
Tofacitinib Efficacy in Patients with Rheumatoid Arthritis and Probable Depression/Anxiety: Post Hoc Analysis of Phase 3 and 3b/4 Randomized Controlled Trials
Gustavo Citera, Rakesh Jain, Fedra Irazoque, et al.
ACR Open Rheumatology
|
October 30, 2025
Characterization of Second-Line Therapy After First JAK Inhibitor Use: Results From the CorEvitas Rheumatoid Arthritis Registry
Joshua F Baker, Kristi V Mizelle, Wassim Saikali, et al.
Rheumatology and Therapy
|
September 25, 2024
Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status
Alexis Ogdie, Lars E Kristensen, Enrique R Soriano, et al.
RMD Open
|
November 2, 2019
Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial
Vibeke Strand, Eduardo Mysler, Robert J Moots, et al.
Page
of 7